Contaminated powdered infant formulas recalled
After a quality-assurance inspection of its manufacturing plant in Michigan revealed contamination by insect pieces and larvae, Abbott notified FDA that it was suspending production and issued a voluntary recall for about 5 million containers of certain Similac-brand powdered infant formulas.
After a quality-assurance inspection of its manufacturing plant in Michigan revealed contamination by insect pieces and larvae, Abbott notified FDA that it was suspending production and issued a voluntary recall for about 5 million containers of certain Similac-brand powdered infant formulas.
The recall includes milk- and soy-based formulas of Similac, Isomil, and Go & Grow in plastic containers and cans distributed in the United States, Puerto Rico, Guam, and several Caribbean nations. No liquid infant formulas are affected by the recall.
FDA says that the contaminated formula poses no immediate health risk but cautions there is the possibility that infants who ingest formula containing insect parts could experience gastrointestinal discomfort and could refuse to eat.
Major congenital malformations not linked to first trimester tetracycline use
November 22nd 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Higher pregnancy risks associated with maternal hidradenitis suppurativa
November 8th 2024A study of over 1 million births in Quebec reveals that pregnant women with hidradenitis suppurativa face increased risks of pregnancy complications and long-term health issues for both themselves and their offspring.
Low vitamin D levels associated with slowed fracture healing
September 29th 2024“Getting outside and enjoying the fresh air can do wonders for your health while also upping Vitamin D absorption, said Jessica McQuerry, MD, lead study author of an abstract presented at the 2024 AAP National Conference & Exhibition.
